Literature DB >> 18194214

Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.

Daniela Silva-Adaya1, Verónica Pérez-De La Cruz, María Nieves Herrera-Mundo, Karina Mendoza-Macedo, Juana Villeda-Hernández, Zbigniew Binienda, Syed F Ali, Abel Santamaría.   

Abstract

Excitotoxicity and disrupted energy metabolism are major events leading to nerve cell death in neurodegenerative disorders. These cooperative pathways share one common aspect: triggering of oxidative stress by free radical formation. In this work, we evaluated the effects of the antioxidant and energy precursor, levocarnitine (L-CAR), on the oxidative damage and the behavioral, morphological, and neurochemical alterations produced in nerve tissue by the excitotoxin and free radical precursor, quinolinic acid (2,3-pyrindin dicarboxylic acid; QUIN), and the mitochondrial toxin, 3-nitropropionic acid (3-NP). Oxidative damage was assessed by the estimation of reactive oxygen species formation, lipid peroxidation, and mitochondrial dysfunction in synaptosomal fractions. Behavioral, morphological, and neurochemical alterations were evaluated as markers of neurotoxicity in animals systemically administered with L-CAR, chronically injected with 3-NP and/or intrastriatally infused with QUIN. At micromolar concentrations, L-CAR reduced the three markers of oxidative stress stimulated by both toxins alone or in combination. L-CAR also prevented the rotation behavior evoked by QUIN and the hypokinetic pattern induced by 3-NP in rats. Morphological alterations produced by both toxins (increased striatal glial fibrillary acidic protein-immunoreactivity for QUIN and enhanced neuronal damage in different brain regions for 3-NP) were reduced by L-CAR. In addition, L-CAR prevented the synergistic action of 3-NP and QUIN to increase motor asymmetry and depleted striatal GABA levels. Our results suggest that the protective properties of L-CAR in the neurotoxic models tested are mostly mediated by its characteristics as an antioxidant agent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18194214     DOI: 10.1111/j.1471-4159.2007.05174.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  30 in total

1.  Propolis ameliorates tumor nerosis factor-α, nitric oxide levels, caspase-3 and nitric oxide synthase activities in kainic acid mediated excitotoxicity in rat brain.

Authors:  Mummedy Swamy; Dian Suhaili; K N S Sirajudeen; Zulkarnain Mustapha; Chandran Govindasamy
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-08-23

2.  Huntington's disease and mitochondrial alterations: emphasis on experimental models.

Authors:  Verónica Pérez-De la Cruz; Paul Carrillo-Mora; Abel Santamaría
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

3.  Early nerve ending rescue from oxidative damage and energy failure by L: -carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities.

Authors:  Diana Elinos-Calderón; Yolanda Robledo-Arratia; Verónica Pérez-De La Cruz; José Pedraza-Chaverrí; Syed F Ali; Abel Santamaría
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

4.  The Antiepileptic Drug Levetiracetam Protects Against Quinolinic Acid-Induced Toxicity in the Rat Striatum.

Authors:  Maricela Dircio-Bautista; Ana Laura Colín-González; Gabriela Aguilera; Marisol Maya-López; Juana Villeda-Hernández; Sonia Galván-Arzate; Esperanza García; Isaac Túnez; Abel Santamaría
Journal:  Neurotox Res       Date:  2017-11-09       Impact factor: 3.911

Review 5.  Modification of Astrocyte Metabolism as an Approach to the Treatment of Epilepsy: Triheptanoin and Acetyl-L-Carnitine.

Authors:  Mussie Ghezu Hadera; Tanya McDonald; Olav B Smeland; Tore W Meisingset; Haytham Eloqayli; Saied Jaradat; Karin Borges; Ursula Sonnewald
Journal:  Neurochem Res       Date:  2015-10-03       Impact factor: 3.996

6.  Chronic pretreatment with acetyl-L-carnitine and ±DL-α-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function.

Authors:  G Nagesh Babu; Alok Kumar; Ram Lakhan Singh
Journal:  Neurotox Res       Date:  2010-03-09       Impact factor: 3.911

7.  Comparison of the Toxic Effects of Quinolinic Acid and 3-Nitropropionic Acid in C. elegans: Involvement of the SKN-1 Pathway.

Authors:  Ilan Kotlar; Aline Colonnello; María Fernanda Aguilera-González; Daiana Silva Avila; María Eduarda de Lima; Rodolfo García-Contreras; Alma Ortíz-Plata; Félix Alexandre Antunes Soares; Michael Aschner; Abel Santamaría
Journal:  Neurotox Res       Date:  2017-08-18       Impact factor: 3.911

8.  Effects of single-dose neuropeptide Y on levels of hippocampal BDNF, MDA, GSH, and NO in a rat model of pentylenetetrazole-induced epileptic seizure.

Authors:  Hale Maral Kir; Deniz Sahin; Berrin Oztaş; Mert Musul; Sevinc Kuskay
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

9.  L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.

Authors:  Angela Sitta; Alethéa G Barschak; Marion Deon; Jurema F de Mari; Amanda T Barden; Camila S Vanzin; Giovana B Biancini; Ida V D Schwartz; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2008-09-24       Impact factor: 5.046

10.  Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine.

Authors:  Diana Elinos-Calderón; Yolanda Robledo-Arratia; Verónica Pérez-De La Cruz; Perla D Maldonado; Sonia Galván-Arzate; José Pedraza-Chaverrí; Abel Santamaría
Journal:  J Neural Transm (Vienna)       Date:  2009-10-29       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.